Biodexa Pharmaceuticals Plc (BDRX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Biodexa Pharmaceuticals Plc (BDRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $544,662, listed on NASDAQ, employing roughly 11 people, carrying a beta of 1.19 to the broader market. Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Led by Stephen Anthony Stamp, public since 2015-12-07.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for BDRX as of 2026-09-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →